S-1, Irinotecan, Bevacizumab
Sponsors
Taiho Pharmaceutical Co., Ltd.
Conditions
Colorectal CancerColorectal, Cancer
Phase 2
Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer
CompletedNCT00569335
Start: 2007-10-31End: 2010-03-31Updated: 2012-11-02
Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer
CompletedNCT00569790
Start: 2007-10-31End: 2010-03-31Updated: 2012-11-02